BlackRock’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.9M Buy
11,536,321
+741,720
+7% +$3.46M ﹤0.01% 2374
2025
Q1
$59.3M Sell
10,794,601
-26,527
-0.2% -$146K ﹤0.01% 2267
2024
Q4
$36.7M Buy
10,821,128
+87,097
+0.8% +$295K ﹤0.01% 2618
2024
Q3
$30.6M Buy
10,734,031
+401,953
+4% +$1.15M ﹤0.01% 2737
2024
Q2
$23.2M Buy
10,332,078
+371,572
+4% +$836K ﹤0.01% 2842
2024
Q1
$22M Sell
9,960,506
-50,885
-0.5% -$112K ﹤0.01% 2886
2023
Q4
$23.5M Buy
10,011,391
+637,149
+7% +$1.5M ﹤0.01% 2864
2023
Q3
$17.4M Buy
9,374,242
+39,646
+0.4% +$73.7K ﹤0.01% 2970
2023
Q2
$24.5M Buy
9,334,596
+921,416
+11% +$2.41M ﹤0.01% 2848
2023
Q1
$13.7M Sell
8,413,180
-163,033
-2% -$266K ﹤0.01% 3095
2022
Q4
$11.4M Buy
8,576,213
+347,585
+4% +$462K ﹤0.01% 3273
2022
Q3
$12.8M Buy
8,228,628
+221,834
+3% +$346K ﹤0.01% 3227
2022
Q2
$12.3M Buy
8,006,794
+6,011,915
+301% +$9.26M ﹤0.01% 3328
2022
Q1
$5.11M Buy
1,994,879
+199,366
+11% +$510K ﹤0.01% 3871
2021
Q4
$5.26M Buy
1,795,513
+269,705
+18% +$790K ﹤0.01% 3914
2021
Q3
$3.74M Sell
1,525,808
-158,358
-9% -$388K ﹤0.01% 3995
2021
Q2
$6.86M Sell
1,684,166
-2,080,782
-55% -$8.47M ﹤0.01% 3721
2021
Q1
$17M Buy
3,764,948
+117,730
+3% +$531K ﹤0.01% 3215
2020
Q4
$17.9M Buy
3,647,218
+104,388
+3% +$514K ﹤0.01% 2998
2020
Q3
$21M Buy
3,542,830
+727,982
+26% +$4.32M ﹤0.01% 2768
2020
Q2
$7.49M Buy
2,814,848
+478,430
+20% +$1.27M ﹤0.01% 3288
2020
Q1
$4.56M Buy
2,336,418
+139,671
+6% +$272K ﹤0.01% 3336
2019
Q4
$15.5M Buy
2,196,747
+65,498
+3% +$462K ﹤0.01% 2984
2019
Q3
$20.9M Sell
2,131,249
-7,532
-0.4% -$74K ﹤0.01% 2765
2019
Q2
$24.5M Buy
2,138,781
+348,308
+19% +$3.98M ﹤0.01% 2714
2019
Q1
$18M Buy
1,790,473
+1,145,438
+178% +$11.5M ﹤0.01% 2786
2018
Q4
$11M Buy
645,035
+250,619
+64% +$4.26M ﹤0.01% 3026
2018
Q3
$6.93M Buy
394,416
+369,416
+1,478% +$6.49M ﹤0.01% 3361
2018
Q2
$475K Buy
+25,000
New +$475K ﹤0.01% 4061